Science Explorer Back to mapMap
Discussion
Topic · Surgery

Esophageal and GI Pathology

Esophageal and GI Pathology is a research topic within Surgery. Science Explorer counts 58k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the evolving techniques and advancements in the management of esophageal perforation, endoscopic stenting for benign and malignant diseases, palliative treatment of gastric outlet obstruction using self-expanding metal stents, and the use of endoluminal vacuum therapy. It also covers topics such as esophageal atresia, tracheoesophageal fistula, and the management of anastomotic leaks.

  • Esophageal Perforation
  • Endoscopic Stenting
  • Gastric Outlet Obstruction
  • Self-Expanding Metal Stents
  • Benign and Malignant Diseases
  • Anastomotic Leaks
  • Esophageal Atresia
  • Tracheoesophageal Fistula
  • Endoluminal Vacuum Therapy
  • Palliative Treatment
Research works
58k
fractional, since 1950
In the world top 10%
5.8k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+1%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Esophageal and GI Pathology

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Esophageal and GI Pathology research?

By volume, the United States and China publish the most (2.3k and 1.3k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.3k works
  2. 2 China 1.3k works
  3. 3 Japan 1.2k works
  4. 4 India 598 works
  5. 5 United Kingdom 560 works
  6. 6 Italy 409 works
  7. 7 Germany 366 works
  8. 8 Spain 301 works
  9. 9 South Korea 262 works
  10. 10 Brazil 259 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.0%China: 17.3%Japan: 15.3%India: 7.9%6 others listed: 28.5%31%largest
United States2,350 · 31.0%China1,309 · 17.3%Japan1,162 · 15.3%India598 · 7.9%6 others listed2,157 · 28.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Esophageal and GI Pathology research?

By volume in 2022-now, Mayo Clinic publishes the most Esophageal and GI Pathology research, followed by Harvard University and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 72 works
  2. 2 Harvard UniversityUnited States 70 works
  3. 3 All India Institute of Medical SciencesIndia 56 works
  4. 4 Sichuan UniversityChina 55 works
  5. 5 Cleveland ClinicUnited States 45 works
  6. 6 University College LondonUnited Kingdom 44 works
  7. 7 Zhengzhou UniversityChina 43 works
  8. 8 Shanghai Jiao Tong UniversityChina 39 works
  9. 9 Sun Yat-sen UniversityChina 38 works
  10. 10 Universidade de São PauloBrazil 35 works

Who are the leading researchers in Esophageal and GI Pathology?

The most-cited researchers publishing on Esophageal and GI Pathology include Freddie Bray, Zhong Lin Wang and George Davey Smith.

  1. 1 Freddie Bray France 550k citations
  2. 2 Zhong Lin Wang United States 491k citations
  3. 3 George Davey Smith United Kingdom 435k citations
  4. 4 Walter Churchill Willett United States 411k citations
  5. 5 Bert Vogelstein United States 373k citations
  6. 6 Jun Wang China 340k citations
  7. 7 Graeme J. Hankey Australia 316k citations
  8. 8 Gregory Y.H. Lip United Kingdom 311k citations
  9. 9 Dan J. Stein South Africa 306k citations
  10. 10 Salim Yusuf Canada 294k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Esophageal and GI Pathology?

The most cited paper in Esophageal and GI Pathology is "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase" (Phyllis Frosst, Henk J. Blom, Renate Milos et al., 1995), with 5,732 citations. Next come "Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma" (3,048) and "Endoscopic sphincterotomy complications and their management: an attempt at consensus" (2,873).

Most cited papers
#PaperReleasedCitations
1 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Phyllis Frosst, Henk J. Blom, Renate Milos et al. · Nature Genetics Open access May 1995 5,732
2 Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma Jesper Lagergren, Reinhold Bergström, Anders Lindgren et al. · New England Journal of Medicine 18 Mar 1999 3,048
3 Endoscopic sphincterotomy complications and their management: an attempt at consensus Peter B. Cotton, Glen A. Lehman, Jack A. Vennes et al. · Gastrointestinal Endoscopy May 1991 2,873
4 Esophageal Cancer Peter C. Enzinger, Robert J. Mayer · New England Journal of Medicine 3 Dec 2003 2,525
5 A lexicon for endoscopic adverse events: report of an ASGE workshop Peter B. Cotton, Glenn M. Eisen, Lars Aabakken et al. · Gastrointestinal Endoscopy 27 Feb 2010 2,504
All 100 most cited papers, with filters and sorting

Where is Esophageal and GI Pathology research done?

The largest centres of Esophageal and GI Pathology research in 2022-now are Tokyo (Japan), London (United Kingdom), Beijing (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano.

Largest cities, 2022-now

  1. 1 TokyoJapan 269 works
  2. 2 LondonUnited Kingdom 172 works
  3. 3 BeijingChina 137 works
  4. 4 SeoulSouth Korea 117 works
  5. 5 ShanghaiChina 106 works
  6. 6 New YorkUnited States 98 works
  7. 7 MoscowRussia 90 works
  8. 8 ChengduChina 89 works
  9. 9 OsakaJapan 83 works
  10. 10 São PauloBrazil 80 works

Where it is the local speciality

  1. RozzanoIT · 27.8 works17×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Esophageal and GI Pathology than the world average.

See Esophageal and GI Pathology on the map

Where is the best place to study Esophageal and GI Pathology?

Among universities, judged by research, University of Amsterdam, University College London and Harvard University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 18.37%fractional works in this field (log) →share of work in the world top 10% →University of Amster…Karolinska InstitutetHarvard UniversityUniversity College L…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of AmsterdamNetherlands 65.328.2%2.4×13 +19.0%
2University College LondonUnited Kingdom 65.013.9%3.0×44 +17.9%
3Harvard UniversityUnited States 62.815.0%2.4×70 -34.2%
4Karolinska InstitutetSweden 62.222.0%4.4×23 -11.9%
5University of PaduaItaly 62.022.0%2.9×21 +45.9%
6Humanitas UniversityItaly 61.512.3%20.2×27 +11.0%
7Utrecht UniversityNetherlands 58.927.3%2.2×15 -38.5%
8Northwestern UniversityUnited States 57.020.1%3.6×28 -23.9%
9SHOWA Medical UniversityJapan 55.412.9%28.4×26 +20.7%
10Sichuan UniversityChina 55.310.0%2.6×55 +12.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Esophageal and GI Pathology, country by country

Is Esophageal and GI Pathology research growing?

Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2020. The fastest-growing topics are Esophageal and GI Pathology.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Esophageal and GI Pathology as a percentage of every work published that year, 0.048% in 2024.

still counting0.025%0.050%0.075%Esophageal and GI Pathology0.044% in 202519801990200020102020

Fractional works of Esophageal and GI Pathology over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Esophageal and GI Pathology10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Esophageal and GI Pathology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.